Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04121312
Other study ID # IRB201902013
Secondary ID OCR26064
Status Completed
Phase N/A
First received
Last updated
Start date October 28, 2019
Est. completion date July 24, 2020

Study information

Verified date January 2024
Source University of Florida
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The overall aim of this study is to evaluate the acceptability and feasibility of a primary-care based approach to facilitating engagement in online behavior tracking and community support networks for weight loss ("facilitation condition") over 12 weeks among adults with obesity.


Recruitment information / eligibility

Status Completed
Enrollment 33
Est. completion date July 24, 2020
Est. primary completion date July 7, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - PCPs: 1. Employed as a PCP at a clinics in the UF health care system. 2. Has practiced at current clinic for =1 year (self-report) 3. Is employed = 0.5 FTE (self-report) 4. Has a patient panel that is majority adult (self-report) - Patients: EHR-based criteria: 1. Age 18-75 2. Last BMI in EHR =30 kg/m2 3. Has an appointment scheduled ("index appointment") with an enrolled primary care PCP 7-30 days after electronic data pull. 4. Is enrolled in MyChart or has an email address in the IDR system. Self-report criteria: 5. Self-reported BMI > 29 kg/m2 (to account for under-reporting) 6. Response yes to question: "Would you be interested in learning strategies to help you lose weight?" 7. Ability to read and understand English without assistance. 8. Has either (a) a phone or tablet with a data plan OR (b) reliable access to Wi-Fi (via computer, phone or tablet) in their home. Exclusion Criteria: - PCPs: 1. Planning to move out of the Gainesville or Jacksonville area in the next 12 months. - Patients: 1. Currently enrolled in formal weight loss program or a research study focused on changing diet, physical activity, or weight. 2. In past month, has tracked the majority of their food intake on an app, website, or paper log an average of 3 or more days per week. 3. Self-reported to be pregnant, breastfeeding, or planning to become pregnant in next 6 months. 4. Currently undergoing radiation or chemotherapy for cancer. 5. Self-reported cardiac event in past 6 months. 6. Self-reported Heart Failure (also known as chronic heart failure or CHF). 7. Planning to move out of the Gainesville or Jacksonville area (depending on which clinic they are recruited from) in the next 6 months.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Facilitation Intervention
See "arm" description

Locations

Country Name City State
United States UF Health at the University of Florida Gainesville Florida
United States UF Health - Jacksonville Jacksonville Florida

Sponsors (1)

Lead Sponsor Collaborator
University of Florida

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Patient retention Percent of enrolled patients completing the 12-week follow-up assessment. (NOTE: this is a feasibility pilot and is not conceptualized as having a single primary outcome) 12 weeks
Secondary Provider retention Percent of enrolled providers who complete telephone interview at end of study 4-6 months (depends on patient recruitment rate)
Secondary Percent of contacted providers who enroll Percent of PCPs offered the study who consent NA (depends on period of recruitment, approx 1 month)
Secondary Percent of patients who enroll Percent of patients contacted who are eligible and agree to participate. NA (depends on period of recruitment, approx 2-4 months)
Secondary Rate of patient recruitment Patients recruited per month during active recruitment periods up to 16 weeks
Secondary Acceptability of intervention- provider Response to 5 study specific questions asking about alignment with priorities, fit in workflow, feasibility, perception of patient benefit, and time. Also, response to open ended question about acceptability. At end of intervention (about 4-6 months after start, depending on recruitment rate)
Secondary Acceptability of intervention- patient: 12 study specific questions Response to 12 study specific questions asking about experience with "Weight Loss Your Way" kickoff materials; open ended response to questions about acceptability of intervention during qualitative interviews (of portion of enrollees) 12 weeks
Secondary Initial engagement in Tracking tool and social network Portion of patients who initially engage with tracking tool (i.e., log at least one food item or physical activity) and with social network (i.e., who report reading message board or posting at least once) (tracking and social network examined separately) 12 weeks
Secondary Sustained engagement in Tracking tool and social network Portion of patients who have used the tracking tool and social network at least once in past week at 12 week assessment (tracking and social network examined separately) 12 week assessment (queried about prior week)
Secondary Weight change Mean weight loss (kgs) and portion of participants achieving 3% body weight loss. baseline to 12 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2